Showing results (1641-1650 of 4,538) with videos related to
Sort By:
Pageof 454
Schizophrenia Bulletin|January 1, 1991
A selective review of biological markers in schizophreniaS Szymanski, J M Kane, J A LiebermanSchizophrenia Bulletin|January 1, 1991
Obstacles to clinical research and new drug development in schizophreniaJ M KaneSchizophrenia Bulletin|January 1, 1991
Maintenance medication for schizophrenia: strategies for dose reductionN R SchoolerSchizophrenia Bulletin|May 17, 2007
Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal functionWilliam S Stone, Larry J SeidmanSchizophrenia Bulletin|May 24, 2007
Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia?Steven R LavioletteSchizophrenia Bulletin|April 7, 2007
Is COMT a susceptibility gene for schizophrenia?Hywel J Williams, Michael J Owen, Michael C O'DonovanSchizophrenia Bulletin|April 4, 2007
Anti-Toxoplasma gondii antibodies in patients with schizophrenia--preliminary findings in a Turkish sampleZafer Cetinkaya, Suleyman Yazar, Omer Gecici, et al.Schizophrenia Bulletin|April 4, 2007
Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?Alison R Yung, Hok Pan Yuen, Gregor Berger, et al.Schizophrenia Bulletin|May 19, 2006
Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk StudiesLarry J Seidman, Anthony J Giuliano, Christopher W Smith, et al.Schizophrenia Bulletin|June 20, 2006
Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosisWarrick J Brewer, Stephen J Wood, Lisa J Phillips, et al.Pageof 454